First Time Loading...

Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 138.7 USD -0.56% Market Closed
Updated: Mar 29, 2024

Dexcom Inc
Operating Income

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Dexcom Inc
Operating Income Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Dexcom Inc
NASDAQ:DXCM
Operating Income
$614.3m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.1B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
5%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.4B
CAGR 3-Years
39%
CAGR 5-Years
7%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Operating Income
$4.4B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.7B
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
12%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$1.8B
CAGR 3-Years
19%
CAGR 5-Years
7%
CAGR 10-Years
8%

See Also

What is Dexcom Inc's Operating Income?
Operating Income
614.3m USD

Based on the financial report for Dec 31, 2023, Dexcom Inc's Operating Income amounts to 614.3m USD.

What is Dexcom Inc's Operating Income growth rate?
Operating Income CAGR 3Y
24%

Over the last year, the Operating Income growth was 52%. The average annual Operating Income growth rates for Dexcom Inc have been 24% over the past three years .